Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-4-13
pubmed:abstractText
To determine whether specific c-Mpl mutations might respond to thrombopoietin receptor agonists.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-10077649, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-10233424, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-11133753, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-15001470, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-16115772, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-16351641, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-16470591, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-17147697, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-17289815, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-18242413, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-18487512, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-18981291, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-19231632, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-19302922, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-8662939, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-8695859, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-9030560, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-9122198, http://linkedlifedata.com/resource/pubmed/commentcorrection/20188141-9774108
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1873-2399
pubmed:author
pubmed:copyrightInfo
2010 ISEH Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
384-91
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed-meshheading:20188141-Animals, pubmed-meshheading:20188141-Cell Line, pubmed-meshheading:20188141-Cell Membrane, pubmed-meshheading:20188141-Humans, pubmed-meshheading:20188141-Hydrogen Bonding, pubmed-meshheading:20188141-Interleukin-3, pubmed-meshheading:20188141-Lymphocytes, pubmed-meshheading:20188141-Mice, pubmed-meshheading:20188141-Mutagenesis, Site-Directed, pubmed-meshheading:20188141-Peptides, pubmed-meshheading:20188141-Phosphorylation, pubmed-meshheading:20188141-Point Mutation, pubmed-meshheading:20188141-Protein Binding, pubmed-meshheading:20188141-Protein Interaction Mapping, pubmed-meshheading:20188141-Protein Processing, Post-Translational, pubmed-meshheading:20188141-Protein Structure, Tertiary, pubmed-meshheading:20188141-Receptors, Thrombopoietin, pubmed-meshheading:20188141-Recombinant Fusion Proteins, pubmed-meshheading:20188141-Recombinant Proteins, pubmed-meshheading:20188141-Thrombocytopenia, pubmed-meshheading:20188141-Thrombopoiesis, pubmed-meshheading:20188141-Thrombopoietin
pubmed:year
2010
pubmed:articleTitle
F104S c-Mpl responds to a transmembrane domain-binding thrombopoietin receptor agonist: proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents.
pubmed:affiliation
Pediatric Hematology-Oncology, University of California, San Diego, La Jolla, Calif. 92017, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural